Patent Assignment
Reel/Frame 034791/0384
Assignment of Assignor's Interest
Recorded: 2015-01-22
Pages: 5
Assignor
EUTHYMICS BIOSCIENCE, INC.
Executed: 2011-12-22
Assignee
NEUROVANCE, INC.
43 THORNDIKE STREET, SUITE S1-3, CAMBRIDGE, MASSACHUSETTS, 02141
Covered Properties
(3)
Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
Application:
13/528,940 →
Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
Application:
13/751,169 →
Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
Application:
13/907,921 →
Publication:
US 2014/0206740
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 22, 2015
From: MCKINNEY, ANTHONY; BYMASTER, FRANK
To: NEUROVANCE, INC.
Reel/Frame 034791/0696 →
Assignment of Assignor's Interest
Jan 22, 2015
From: BYMASTER, FRANK; MCKINNEY, ANTHONY ALEXANDER
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 034791/0008 →
Assignment of Assignor's Interest
Oct 28, 2016
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 040512/0162 →
Merger
Dec 13, 2017
From: NEUROVANCE, INC.
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 044867/0815 →